http://www.ng2000.com/fw.php?tp=arthritis
06/17/2008: Tokyo, June 17, 2008 - (JCN Newswire) - On June 17, 2008, Abbott Japan Co., Ltd. (Pharmaceutical Products Group in Tokyo, President: Glenn S. Warner) and Eisai Co., Ltd. (Headquarters in Tokyo, President and CEO: Haruo Naito) announced that
HUMIRA(R) subcutaneous injection 40mg Syringe 0.8mL (referred to as HUMIRA hereinafter) will be available for the treatment of rheumatoid arthritis from June ...